Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Azithromycin ER vs IR in Pediatric AOM
NCT00796224Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2008
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of azithromycin in acute otitis media (AOM) (2 arms), sponsored by Pfizer. Primary endpoint: Area Under the Curve From Time Zero to 72 Hours. Started Dec 2008; status: completed.
02
Drugs
azithromycin
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on NCT00796224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00796224.